A detailed history of Nisa Investment Advisors, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 24,300 shares of NTRA stock, worth $4.06 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
24,300
Previous 24,300 -0.0%
Holding current value
$4.06 Million
Previous $2.63 Million 17.37%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$85.28 - $112.6 $51,168 - $67,560
-600 Reduced 2.41%
24,300 $2.63 Million
Q3 2022

Nov 07, 2022

SELL
$36.93 - $56.68 $4,727 - $7,255
-128 Reduced 0.51%
24,900 $1.09 Million
Q2 2022

Aug 03, 2022

BUY
$28.13 - $44.54 $343,186 - $543,388
12,200 Added 95.1%
25,028 $887,000
Q4 2021

Feb 03, 2022

SELL
$86.26 - $119.0 $222,205 - $306,544
-2,576 Reduced 16.72%
12,828 $906,000
Q3 2021

Oct 18, 2021

SELL
$100.17 - $126.36 $287,387 - $362,526
-2,869 Reduced 15.7%
15,404 $1.72 Million
Q1 2021

Apr 26, 2021

BUY
$91.47 - $124.36 $18,294 - $24,872
200 Added 1.11%
18,273 $1.86 Million
Q4 2020

Jan 25, 2021

BUY
$66.66 - $111.74 $193,180 - $323,822
2,898 Added 19.1%
18,073 $1.8 Million
Q3 2020

Oct 20, 2020

BUY
$45.89 - $72.67 $82,143 - $130,079
1,790 Added 13.37%
15,175 $1.1 Million
Q2 2020

Jul 27, 2020

BUY
$26.36 - $49.86 $2,240 - $4,238
85 Added 0.64%
13,385 $667,000
Q1 2020

Apr 17, 2020

BUY
$17.27 - $40.17 $10,362 - $24,102
600 Added 4.72%
13,300 $397,000
Q4 2018

Jan 17, 2019

BUY
$12.32 - $24.38 $1,232 - $2,438
100 Added 0.79%
12,700 $177,000
Q1 2018

Apr 10, 2018

BUY
$9.0 - $11.95 $27,000 - $35,850
3,000 Added 31.25%
12,600 $117,000
Q4 2017

Jan 12, 2018

BUY
$8.99 - $14.31 $11,687 - $18,603
1,300 Added 15.66%
9,600 $86,000
Q3 2017

Oct 13, 2017

BUY
$8.02 - $13.33 $66,566 - $110,639
8,300
8,300 $107,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.